Common Culprits: Staphylococcus aureus, other Staphylococcus species, Viridans streptococci, other streptococci, gram-negative bacilli, polymicrobial
Treatment:
Due to penicillin-susceptible viridans streptococci and Streptococcus gallolyticus (bovis)
4 Week Regimens
Aqueous penicillin G 200,000 to 300,000 units/kg per 24 hours IV in 6 divided doses (maximum dose: 24 million units per 24 hours)
Ampicillin 200 to 300 mg/kg per 24 hours IV divided in 4 or 6 divided doses (maximum dose: 12 g per 24 hours)
Ceftriaxone 100 mg/kg per 24 hours IV in 2 divided doses or 80 mg/kg in 1 daily dose (maximum dose: 4 g per 24 hours; if dose is >2 g per 24 hours, use divided dosing every 12 hours)
Beta-lactam-intolerant patients: Vancomycin 40 mg/kg per 24 hours IV in 2 or 3 divided doses (maximum dose: 2 g per 24 hours)
If resistant to Penicillin G add Gentamicin 3 to 6 mg/kg per 24 hours IV in 3 divided doses for first 2 weeks
Due to enterococcal strains susceptible to penicillin and gentamicin
Beta-lactam combination regimen: Ceftriaxone 100 mg/kg per 24 hours IV in 2 divided doses or 80 mg/kg in 1 daily dose (maximum dose: 4 g per 24 hours; if dose is >2 g per 24 hours, use divided dosing every 12 hours) for 6 weeks plus Ampicillin 200 to 300 mg/kg per 24 hours IV divided in 4 or 6 divided doses (maximum dose: 12 g per 24 hours) for 6 weeks
Aminoglycoside combination regimen: Aqueous penicillin G 200,000 to 300,000 units/kg per 24 hours IV in 6 divided doses (maximum dose: 24 million units per 24 hours) for 4 to 6 weeks or Ampicillin 200 to 300 mg/kg per 24 hours IV divided in 4 or 6 divided doses (maximum dose: 12 g per 24 hours) for 4 to 6 weeks plus Gentamicin 3 to 6 mg/kg per 24 hours IV in 2 or 3 divided doses for 4 to 6 weeks
Due to Staphylococcus
Methicillin-susceptible strains
Nafcillin or oxacillin 200 mg/kg per 24 hours IV (maximum dose: 12 g per 24 hours) in 4 or 6 divided doses for 4 to 6 weeks
Cefazolin 100 mg/kg per 24 hours IV (maximum dose: 6 g per 24 hours) in 3 divided doses for 4 to 6 weeks
Methicillin-resistant strains
Vancomycin 40 mg/kg per 24 hours IV (maximum dose: 2 g per 24 hours unless levels are inappropriately low) in 2 or 3 divided doses for 6 weeks
Due to Gram-negative organisms
Monotherapy
Ceftriaxone 100 mg/kg per 24 hours IV in 2 divided doses, or 80 mg/kg in 1 daily dose (maximum dose: 4 g per 24 hours; if dose is >2 g per 24 hours, use divided dosing every 12 hours) for 4 weeks
Cefotaxime 200 mg/kg per 24 hours IV in 4 divided doses (maximum dose: 12 g per 24 hours) for 4 weeks
Combination therapy
Ampicillin 200 to 300 mg/kg per 24 hours IV divided in 4 or 6 divided doses (maximum dose: 12 g per 24 hours) for 4 weeks plus Gentamicin 3 to 6 mg/kg per 24 hours IV in 3 divided doses for 4 weeks
Special Considerations: Inpatient most likely, consult with an infectious disease specialist (especially for Enterococci)
Common Culprit: Bordetella pertussis
First and Second line oral treatment by age group:
<1 month
Azithromycin 10 mg/kg per day in a single dose for 5 day
1 through 5 months
Azithromycin 10 mg/kg per day in a single dose for 5 days
Erythromycin 40 mg/kg per day in 4 divided doses for 14 days
Clarithromycin 15 mg/kg per day in 2 divided doses for 7 days
Infants (aged ≥6 months) and children
Azithromycin 10 mg/kg in a single dose on day 1 (maximum: 500 mg); then 5 mg/kg per day (maximum: 250 mg) on days 2 through 5
Erythromycin 40 mg/kg per day in 4 divided doses for 7 to 14 days (maximum: 2 g per day)
Clarithromycin 15 mg/kg per day in 2 divided doses for 7 days (maximum: 1 g per day)
Adults
Azithromycin 500 mg in a single dose on day 1 then 250 mg per day on days 2 through 5 (preferred in pregnant patients)
Erythromycin 2 g (base) per day in 4 divided doses for 7 to 14 days
Clarithromycin 15 mg/kg per day in 2 divided doses for 7 days (maximum: 1 g per day)
Special Considerations: Alternative agent to macrolides is trimethoprim-sulfamethoxazole (cotrimoxazole)
Common Culprits: S. pneumoniae (most common), M. pneumoniae (more common among children ≥5 years), C. pneumoniae ( more common in older children and young adults), H. influenzae type b (Hib), nontypeable H. influenzae, Moraxella catarrhalis, S. aureus, S. pyogenes, and atypical bacteria
Outpatient treatment by age:
One to six months
Infants younger than three to six months of age with suspected bacterial CAP or who are hypoxemic (oxygen saturation <90 percent in room air at sea level) should be admitted to the hospital for empiric therapy
C. trachomatis ("afebrile pneumonia of infancy") infection if afebrile and not hypoxic: Azithromycin 20 mg/kg per day given orally once daily for three days
Bordetella pertussis: See Pertussis section
Six months to five years
Suspect viral
Amoxicillin 90 mg/kg per day in 2 or 3 divided doses (MAX 4 g/day) for 5 days
Amoxicillin-clavulanate 90 mg/kg per day of the amoxicillin component in 2 or 3 divided doses (MAX 4 g/day amoxicillin component) for 5 days
Levofloxacin 16 to 20 mg/kg per day in 2 divided doses (MAX 750 mg/day) for 5 days
PCN allergy option
Clindamycin 30 to 40 mg/kg per day in 3 or 4 divided doses (MAX 1.8 g/day) for 5-10 days
PCN allergy option
Linezolid 30 mg/kg per day in 3 divided doses (MAX 1.8 g/day) for 10 days
PCN allergy option
≥5 years AND Mycoplasma pneumoniae or Chlamydia pneumoniae
Azithromycin 10 mg/kg on day 1 followed by 5 mg/kg daily for 4 more days (MAX 500 mg on day 1 and 250 mg thereafter)
Clarithromycin 15 mg/kg per day in 2 divided doses for 10 days (MAX 1 g/day)
Erythromycin 40 to 50 mg/kg per day in 4 divided doses for 10 days (MAX 2 g/day as base, 3.2 g/day as ethylsuccinate)
Doxycycline 4 mg/kg per day in 2 divided doses for 10 days (MAX 200 mg/day)
Levofloxacin 8 to 10 mg/kg once daily for children 5 to 16 years (MAX 500 mg/day); 500 mg once daily for children ≥16 years for 5 days
Moxifloxacin 400 mg once daily for 5 days (≥18 years)
≥5 years Typical Bacterial
Amoxicillin 90 mg/kg per day in 2 or 3 divided doses (MAX 4 g/day) for 5 days
Levofloxacin 8 to 10 mg/kg once daily for children 5 to 16 years (MAX 750 mg/day); 750 mg once daily for children ≥16 years for 5 days
PCN allergy option
Clindamycin 30 to 40 mg/kg per day in 3 or 4 divided doses (MAX 1.8 g/day) for 5-10 days
PCN allergy option
Linezolid 30 mg/kg per day in 3 divided doses (MAX 1.8 g/day) for children <12 years; 20 mg/kg per day divided in 2 doses (MAX 1.2 g/day) for children ≥12 years for 10 days
PCN allergy option
Special Considerations:
Aspiration pneumonia
Amoxicillin-clavulanate 40 to 50 mg/kg per day in 2 or 3 divided doses (MAX 1.75 g/day amoxicillin component) for 5 days
Clindamycin 30 to 40 mg/kg per day divided in 3 or 4 doses (MAX 1.8 g/day) for 5-10 days
PCN allergy option
Moxifloxacin 400 mg once daily for 5 days (for ≥18 years)
PCN allergy option
This is an Emergency Department condition, will often present with stridor and dyspnea
Common Culprits: S. aureus (most common), S. pneumoniae, group A Streptococcus (Streptococcus pyogenes), alpha-hemolytic streptococci, Moraxella catarrhalis, Haemophilus influenzae
Treatment:
Vancomycin 15 mg/kg per dose every 6 to 8 hours (maximum daily dose: 4 g) PLUS
Ceftriaxone 50 mg/kg per dose every 12 to 24 hours (maximum daily dose: 2 g)
Cefotaxime (if available) 150 to 200 mg/kg per day in 4 divided doses (maximum dose 2 g)
Ampicillin-sulbactam 150 to 200 mg/kg (of ampicillin component) per day in 4 divided doses (maximum daily dose: 8 g)
OR for patients with potential severe hypersensitivity to beta-lactam antibiotics (eg, penicillin, cephalosporin):
Levofloxacin (6 months to 5 years): 10 mg/kg per dose every 12 hours (maximum daily dose: 500 mg), ≥5 years: 10 mg/kg per dose once daily (maximum daily dose: 500 mg)
Ciprofloxacin 20 to 30 mg/kg per day in 2 divided doses (maximum daily dose: 800 mg)
Special Considerations:
In patients with tracheostomy tubes tracheal aspirate should be obtained and antimicrobial therapy chosen as a result of the Gram stain. For empiric therapy amoxicillin-clavulanate, quinolones (eg, ciprofloxacin or levofloxacin), or clindamycin are all good options. A treatment course of three to seven days is generally sufficient for an uncomplicated course of infection.
Common Culprit: Mycobacterium tuberculosis
Treatment by age:
<3 months: 6 month regimen
Isoniazid (10mg/kg, max dose 300mg), rifampin (15 to 20 mg/kg, max dose 600mg), pyrazinamide (35mg/kg, max dose 600mg), and ethambutol (20 mg/kg, max dose 1 g) for eight weeks, followed by isoniazid and rifampin for 16 weeks
3 months to 11 years: 4 month regimen
Isoniazid (10mg/kg, max dose 300mg), rifampin (15 to 20 mg/kg, max dose 600mg), pyrazinamide (35mg/kg, max dose 600mg), and ethambutol (20 mg/kg, max dose 1 g) for eight weeks, followed by isoniazid and rifampin for 8 weeks
12 to 16 years (over 40kg): Rifapentine-moxifloxacin-based regimen
Isoniazid (300mg), pyrazinamide (dosing based on weight; ≥40 to 55 kg: 1 g, ≥55 to 75 kg: 1.5 g, >75 kg: 2 g), rifapentine (1200mg), moxifloxacin (400mg) for eight weeks, followed by isoniazid, rifapentine, and moxifloxacin for 9 weeks
Special Considerations:
Children for whom an empiric treatment regimen for drug-resistant disease may be warranted include:
Children with treatment failure (acid-fast bacilli sputum culture positive after four months of therapy, assuming drug sensitivity testing is not available, or poor response to traditional therapy)
Children with relapse (recurrent TB after apparent cure)
Children with exposure to an individual with infectious drug-resistant pulmonary TB
Children with residence in or travel to a region with high prevalence of drug-resistant TB